Atropine is a non-selective M receptor blocker and belongs to anticholinergic drugs. A few years ago, the National Ophthalmology Research Institute of Singapore released a five-year clinical trial, which proved that atropine can effectively delay the development of myopia, and then the American Ophthalmology Association published a related magazine, so atropine was called the specific medicine for myopia and began to turn red.
However, there are still some doubts about whether atropine can really relieve myopia in China. Therefore, for the sake of safety, the marketing approval of atropine eye drops is very strict. So far, atropine has not been approved for marketing in China, and many experts in the clinical field are controversial about whether this drug can prevent myopia, because atropine eye drops have many related contraindications, the mechanism of preventing myopia is not clear, and there are many disputes about adverse reactions. ?
The vast majority of atropine eye drops sold in the market are produced by Shenyang Qi Xing Eye Drops Co., Ltd., so the atropine eye drops of Qi Xing Co., Ltd. are regarded as abuse of prescription drugs. These stores in Beijing are listed in the form of hospital preparations, but they are not allowed. Because the Drug Administration Law clearly stipulates that preparations prepared by medical institutions cannot be sold in the market, the state has begun to strictly control this drug. ? Abuse of prescription drugs is very dangerous. Many scalpers sell low-concentration atropine eye drops to their parents. They can't guarantee the temperature and efficacy of drugs during transportation. Moreover, children whose parents take drugs do not have a certain degree of true myopia, so parents take drugs by themselves according to their feelings, which is likely to lead to deepening or rebounding myopia.